Involving Nucleic Acid Patents (Class 435/6.1)
  • Patent number: 10745748
    Abstract: In some embodiments, a variety of devices and methods for conducting microfluidic analyses are utilized herein, including devices that can be utilized to conduct thermal cycling reactions such as nucleic acid amplification reactions. The devices include elastomeric components; in some instances, much or all of the device is composed of elastomeric material. Amplification products (amplicons) can be detected and distinguished (whether isolated in a reaction chamber or at any subsequent time) using routine methods for detecting nucleic acids. An example of a detection method includes hybridization to arrays of immobilized oligo or polynucleotides.
    Type: Grant
    Filed: September 18, 2018
    Date of Patent: August 18, 2020
    Assignee: FLUIDIGM CORPORATION
    Inventors: Marc A. Unger, Geoffrey Richard Facer, Barry Clerkson, Christopher G. Cesar, Neil Switz
  • Patent number: 10745697
    Abstract: The invention relates to a method for genotyping individuals, through multiplexing genotyping, when samples carrying different loci of various individuals are pooled and genotyping is performed on this pool.
    Type: Grant
    Filed: January 9, 2015
    Date of Patent: August 18, 2020
    Assignee: LIMAGRAIN EUROPE
    Inventors: Jean-Pierre Martinant, Pascal Flament
  • Patent number: 10738349
    Abstract: This disclosure relates DNA based movement of objects. In certain embodiments, particles, pairs of particles, or a rods are conjugated with single stranded DNA that hybridizes to a single stranded RNA that is conjugated to a substrate. When the DNA particle, pair of particles, or rod interacts with the surface RNA in the presence of an endonuclease, such as RNase H and the DNA hybridizes to the RNA, then the particle, pair of particle, or rod moves along the surface. The complementarity of the DNA and RNA affect the velocity.
    Type: Grant
    Filed: October 24, 2016
    Date of Patent: August 11, 2020
    Assignee: Emory University
    Inventors: Khalid Salaita, Kevin Yehl
  • Patent number: 10738347
    Abstract: Provided herein are reagents and kits for detection of multiple target sequences in a single-tube, single-color assay, and methods of use thereof. In particular, multiplex assays are provided for the detection of Mycobacterium tuberculosis complex target sequences (e.g., katG, rpoB, inhA promotor, pncA, etc.).
    Type: Grant
    Filed: November 18, 2014
    Date of Patent: August 11, 2020
    Assignee: Brandeis University
    Inventors: Lawrence J. Wangh, Kenneth E. Pierce, John E. Rice
  • Patent number: 10739293
    Abstract: A method and device for performing DNA sequencing and extracting structural information from unknown nucleic acid strands. The device includes a microwell structure, where identical DNA strands are immobilized within the microwell structure on a surface of a micro-bead, an active electrode or a porous polymer. The device further includes a CMOS-integrated semiconductor integrated circuit, where the CMOS-integrated semiconductor integrated circuit includes metal layers on a silicon substrate, where the metal layers form an active electrode biosensor. In addition, a sensing electrode is formed by creating openings in a passivation layer of the CMOS-integrated semiconductor integrated circuit to hold a single bead, on which the DNA strands are immobilized.
    Type: Grant
    Filed: April 12, 2016
    Date of Patent: August 11, 2020
    Assignee: Board of Regents, The University of Texas Systems
    Inventors: Arjang Hassibi, Arun Manickam, Rituraj Singh
  • Patent number: 10733438
    Abstract: An eyeball information detection device includes: an acquisition unit configured to acquire a captured image obtained by imaging a region in which there is a probability that a face of an occupant is present in a vehicle by an imaging device provided in proximity to an illumination device that emits light to the region; and a detection unit configured to output eyeball information that corresponds to the captured image by receiving the captured image acquired by the acquisition unit as an input based on a learned model generated by learning a learning image including information similar to the captured image acquired by the acquisition unit and a correct value of the eyeball information on an eyeball of the occupant appearing in the learning image, by machine learning.
    Type: Grant
    Filed: September 23, 2019
    Date of Patent: August 4, 2020
    Assignee: AISIN SEIKI KABUSHIKI KAISHA
    Inventors: Shin Osuga, Takashi Kato, Yuya Yamada, Yuta Kawai
  • Patent number: 10724081
    Abstract: Methods and containers are provided for identifying a species, illustratively a bacterial species. Illustrative methods comprise amplifying various genes in the nucleic acid from the bacterial species in a single reaction mixture using pairs of outer first-stage primers designed to hybridize to generally conserved regions of the respective genes to generate a plurality of first-stage amplicons, dividing the reaction mixture into a plurality of second-stage reactions, each using a unique pair of second-stage primers, each pair of second-stage primers specific for a target bacterial species or subset of bacterial species, detecting which of the second-stage reactions amplified, and identifying the bacterial species based on second-stage amplification.
    Type: Grant
    Filed: July 26, 2017
    Date of Patent: July 28, 2020
    Assignees: BioFire Diagnostics, LLC, University of Utah Research Foundation
    Inventors: Mark Aaron Poritz, Anne Jeannette Blaschke-Bonkowsky
  • Patent number: 10725058
    Abstract: The subject invention provides methods, assays, and products for visual detection of small-molecule targets in a sample in both clinical and field settings within minutes. The subject invention is based on an aptamer sensor that reports the presence of small-molecule target via a sensitive colorimetric signal for naked-eye detection. The aptamer sensor is a CBSAzyme-based sensor having both target-mediated cooperative behavior of the CBSA and peroxidase-mimicking catalytic activity of DNAzyme. The subject invention also provides methods of using the CBSAzyme-based sensor.
    Type: Grant
    Filed: November 2, 2018
    Date of Patent: July 28, 2020
    Assignee: THE FLORIDA INTERNATIONAL UNIVERSITY BOARD OF TRUSTEES
    Inventors: Yi Xiao, Yingping Luo, Haixiang Yu
  • Patent number: 10724074
    Abstract: The present invention provides methods, compositions and devices for stabilizing the extracellular nucleic acid population in a cell-containing biological sample and for stabilizing the transcriptome of contained cells.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: July 28, 2020
    Assignee: Qiagen GmbH
    Inventors: Martin Horlitz, Annabelle Schubert, Markus Sprenger-Haussels, Kalle Günther, Ralf Wyrich, Uwe Oelmüller
  • Patent number: 10718017
    Abstract: The present disclosure relates to nucleic acid probes and kits for determining the length of a region of tandem repeats in a subject's genome and methods of using the DNA probes for determining the length of a region of tandem repeats in a subject's genome. In some embodiments, the region of tandem repeats in telomeres.
    Type: Grant
    Filed: March 31, 2017
    Date of Patent: July 21, 2020
    Assignee: Arizona Board of Regents on behalf of Arizona State University
    Inventors: Wayne Frasch, Fusheng Xiong
  • Patent number: 10718026
    Abstract: The present invention discloses a method of generating subsets of methylation specific markers from a set, having diagnostic power for various diseases, e.g. cancer of thyroid, breast, colon, or leukemia, in diverse samples; identified subsets of that set, as well as methods for the prognosis and diagnosis of diseases.
    Type: Grant
    Filed: January 28, 2010
    Date of Patent: July 21, 2020
    Assignee: AIT Austrian Institute of Technology GMBH
    Inventors: Andreas Weinhausel, Rudolf Pichler, Christa Nohammer
  • Patent number: 10718012
    Abstract: A multiplexed polymerase chain reaction (PCR) DNA detection system and a method for DNA detection within the PCR system are provided. The PCR DNA detection system includes a color charge-coupled device (CCD) camera, fluorophore-quencher probes and an imaging chamber. The fluorophore-quencher probes are selected in response to fluorophores quenched by the fluorophore-quencher probes corresponding to three selected primary colors and peak channel responses of the CCD camera such that emission profiles of the fluorophores substantially match the three selected primary colors and peak emission profiles of the fluorophores correspond to the peak RGB channel responses of the CCD camera. A DNA sample and the fluorophore-quencher probes are located within the imaging chamber. The color CCD camera is focused on the imaging chamber for simultaneous detection of up to three targets from fluorescence of the DNA sample and the fluorophore-quencher probes.
    Type: Grant
    Filed: October 14, 2014
    Date of Patent: July 21, 2020
    Assignee: AGENCY FOR SCIENCE, TECHNOLOGY AND RESEARCH
    Inventors: Jackie Y. Ying, Saravana Kumar Kumarasamy
  • Patent number: 10712331
    Abstract: The invention relates, in part, to systems and methods for scoring a sample containing tumor tissue from a cancer patient. The score is representative of a nearness between at least one pair of cells, a first member of the least one pair of cells expressing a first biomarker and a second member of the at least one pair of cells expressing a second biomarker that is different from the first biomarker. The score obtained from these methods can be indicative of a likelihood that a patient may respond positively to immunotherapy.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: July 14, 2020
    Assignee: Novartis AG
    Inventors: Brian Little, Jennifer Bordeaux
  • Patent number: 10711317
    Abstract: Nucleic acid oligonucleotide sequences are disclosed which include amplification oligomers and probe oligomers which are useful for detecting multiple types of human papillomaviruses (HPV) associated with cervical cancer. Methods for detecting multiple HPV types in biological specimens by amplifying HPV nucleic acid sequences in vitro and detecting the amplified products are disclosed.
    Type: Grant
    Filed: September 25, 2019
    Date of Patent: July 14, 2020
    Assignee: GEN-PROBE INCORPORATED
    Inventors: Sylvia A. Norman, Jennifer J. Bungo, William L. Hanna, Neeraj P. Rao
  • Patent number: 10711266
    Abstract: The present disclosure provides methods and kits for isolating miRNAs from biological fluids.
    Type: Grant
    Filed: October 15, 2018
    Date of Patent: July 14, 2020
    Assignee: Sigma-Aldrich Co. LLC
    Inventor: Carol A. Kreader
  • Patent number: 10689647
    Abstract: This invention relates to compounds, compositions, and methods useful for reducing AT3 target RNA and protein levels via use of dsRNAs, e.g., Dicer substrate siRNA (DsiRNA) agents.
    Type: Grant
    Filed: May 9, 2016
    Date of Patent: June 23, 2020
    Assignee: Dicerna Pharmaceuticals, Inc.
    Inventors: Bob D. Brown, Henryk T. Dudek
  • Patent number: 10683551
    Abstract: This invention provides methods of determining the biological, pathological, genetic, epigenetic or disease status in a biological sample by determining the methylation status of a subpopulation of genomic DNA in the sample.
    Type: Grant
    Filed: January 20, 2017
    Date of Patent: June 16, 2020
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Steven T. Okino, Yan Wang
  • Patent number: 10683331
    Abstract: Described herein are variants of alpha-hemolysin having at least one mutation selected from T12R, T12K, N17R, N17K or combinations of T12 and N17 mutations. The variants in some embodiments may further comprise H144A. The ?-hemolysin variants have a decreased time to thread.
    Type: Grant
    Filed: April 4, 2019
    Date of Patent: June 16, 2020
    Assignee: Roche Sequencing Solutions, Inc.
    Inventors: Michael Dorwart, Daniel Korenblum
  • Patent number: 10682425
    Abstract: Provided are engineered B lymphocytes modified to express one or several different types of microRNAs or anti-miRs where in one embodiments the lymphocytes contain multiple copy numbers of nucleic acids encoding the one or several different types of miRs or anti-miRs. Provided are compositions and methods for treating, ameliorating, or preventing a cancer cell, a breast cancer cell or a triple negative breast cancer, or a breast cancer cell that tests negative for estrogen receptors, progesterone receptors, or HER2, comprising or by administering a composition, formulation or pharmaceutical composition comprising a microRNA or anti-miR.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: June 16, 2020
    Assignee: The Regents of the University of California
    Inventor: Maurizio Zanetti
  • Patent number: 10676778
    Abstract: Methods, devices, systems and compositions for detecting nucleic acids in polymerase chain reaction assays, such as droplet digital polymerase chain reaction (ddPCR) assays, using intercalating dyes. A dual surfactant system with at least one fluorosurfactant and at least one non-ionic non-fluorosurfactant may be employed for droplet generation and nucleic acid detection.
    Type: Grant
    Filed: November 20, 2017
    Date of Patent: June 9, 2020
    Assignee: Bio-Rad Laboratories, Inc.
    Inventors: Adam Lowe, Geoff McDermott, Christopher M. Hindson, Erin R. Chia, Amy L. Hiddessen, Benjamin J. Hindson, Chunxiao Han, Yaqi Wang
  • Patent number: 10674901
    Abstract: The methods and apparatus of the present invention allow the evaluation of inflammation of the esophagus. Measurements may be utilized, for example, to diagnose a disease of the esophagus, to monitor inflammation of the esophagus, or to access the treatment of a disease of the esophagus. In one embodiment, the invention comprises a method for measuring esophageal inflammation comprising deploying a device into the esophagus of a subject, removing the device after a predetermined period of time, analyzing the device for a diagnostic indicator of esophageal inflammation and evaluating the diagnostic indicator to diagnose esophageal inflammation.
    Type: Grant
    Filed: April 27, 2018
    Date of Patent: June 9, 2020
    Assignees: The Regents of the University of Colorado, a body corporate, The Board of Trustees of the University of Illinois
    Inventors: Glenn T. Furuta, Steven J. Ackerman
  • Patent number: 10676770
    Abstract: The invention relates to a method for selective crystallization of 2?-FL from an aqueous solution comprising 2?-FL and one or more other fucosylated carbohydrates by adding acetic acid to the solution.
    Type: Grant
    Filed: December 16, 2015
    Date of Patent: June 9, 2020
    Assignee: GLYCOM A/S
    Inventors: Gyula Dekany, Györgyi Osztrovszky, Martin Matwiejuk, Pierre Chassagne, Markus Jondelius Hederos
  • Patent number: 10669577
    Abstract: This invention provides methods for attaching a nucleic acid to a solid surface and for sequencing nucleic acid by detecting the identity of each nucleotide analogue after the nucleotide analogue is incorporated into a growing strand of DNA in a polymerase reaction. The invention also provides nucleotide analogues which comprise unique labels attached to the nucleotide analogue through a cleavable linker, and a cleavable chemical group to cap the —OH group at the 3?-position of the deoxyribose.
    Type: Grant
    Filed: March 27, 2015
    Date of Patent: June 2, 2020
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Jingyue Ju, Zengmin Li, John Robert Edwards, Yasuhiro Itagaki
  • Patent number: 10669569
    Abstract: Methods for detecting and quantifying an analyte employ a pair of proximity probes, each comprising a proteinaceous target-binding domain coupled to a nucleic acid domain (NAD), which NADs interact when the proximity probes have bound in proximity to their respective target; and a set of markers, wherein each marker is a nucleic acid molecule comprising a binding domain and a reporter domain giving a detectable signal, can interact with said NADs to form a nucleic acid molecule from which a detectable signal is generated, or with a nucleic acid molecule generated by interaction of said NADs, cannot interact with said NADs simultaneously with another marker in the set, generates a signal that is distinguishable from another marker signal, and is present in an amount capable of detecting analyte at a range of concentrations differing from the range of concentrations detectable by other markers.
    Type: Grant
    Filed: October 14, 2011
    Date of Patent: June 2, 2020
    Assignee: Navinci Diagnostics AB
    Inventors: Mats Gullberg, Irene Weibrecht, Carl-Magnus Clausson, Ola Söderberg
  • Patent number: 10672505
    Abstract: Identification of regions-of-interest within cell maps is disclosed. In certain embodiments, identification of the regions-of interest is based on the use of biomarkers selected based on nucleic acid sequence data. The nucleic acid sequence data may be acquired for a homogeneous or heterogeneous set of cells present in the respective tissue sample.
    Type: Grant
    Filed: June 3, 2015
    Date of Patent: June 2, 2020
    Assignee: General Electric Company
    Inventors: Brion Daryl Sarachan, John Frederick Graf, Michael John Gerdes
  • Patent number: 10670595
    Abstract: Systems and methods for detection of analytes by production of electrochemical species are provided. Some embodiments of this invention relate generally to carbon biosensors for detecting an analyte in a biological sample. More specifically, this invention relates generally to immunoassays for detection of analytes utilizing electroactive compounds, and more particularly, relates to diagnostic assays based on signals from electroactive chemical undergoing redox cycling on electrosensor consisting of carbon, to detect analytes wherein a precomplex mixture is formed and a multi-step, or single-step, assay is performed, resulting in greater signal.
    Type: Grant
    Filed: May 26, 2016
    Date of Patent: June 2, 2020
    Assignee: OncoGenesis, Inc.
    Inventors: Peter P. Gombrich, Nam W. Kim, Christopher E. Todd
  • Patent number: 10670611
    Abstract: Methods and computer methods used to assess an individual for the prediction of risk of developing a Cardiovascular (CV) Event over a 1 to 5 year period are provided. The methods employ at least two biomarkers selected from MMP12, angiopoietin-2, complement C7, cardiac troponin I, angiopoietin-related protein 4, CCL18/PARC, alpha-1-antichymotrypsin complex, GDF11 and alpha-2-antiplasmin, or GDF11 in combination with FSTL3. The methods are particularly useful in predicting CV events in patients who suffer from coronary heart disease (CHD).
    Type: Grant
    Filed: November 3, 2014
    Date of Patent: June 2, 2020
    Assignee: SomaLogic, Inc.
    Inventors: David Sterling, Shintaro Kato, Edward N. Brody, Stephen A. Williams
  • Patent number: 10669586
    Abstract: Systems are provided for detecting and quantitating short nucleic acid molecules.
    Type: Grant
    Filed: October 27, 2017
    Date of Patent: June 2, 2020
    Assignee: BIONANO GENOMICS, INC.
    Inventors: Han Cao, Alex R. Hastie, Ernest Tsz-Tsun Lam
  • Patent number: 10669575
    Abstract: Embodiments disclosed herein relate to methods and systems for analysis of melting temperatures, and particularly to analysis of duplex nucleic acids.
    Type: Grant
    Filed: August 25, 2017
    Date of Patent: June 2, 2020
    Assignee: Becton, Dickinson and Company
    Inventor: Adam Steel
  • Patent number: 10662479
    Abstract: Methods of treating a tumor in a subject and methods of determining a treatment regimen for a subject with a tumor are provided herein. In exemplary aspects, the methods comprise measuring the level of expression of immunoglobulin, FCGR2B, a gene listed in Table 4, or a combination thereof. In exemplary aspects, the subject is a subject from which a sample was obtained, wherein the level of immunoglobulin, FCGR2B, a gene listed in Table 4, or a combination thereof, has been measured from the sample. Related kits, computer readable-storage media, systems, and methods implemented by a processor in a computer are further provided.
    Type: Grant
    Filed: August 8, 2014
    Date of Patent: May 26, 2020
    Assignee: Onyx Therapeutics, Inc.
    Inventors: Brian Tuch, Jeremiah Degenhardt, Andrea Loehr, Kevin Kwei, Christopher J. Kirk
  • Patent number: 10663423
    Abstract: A system for detecting electrical properties of a molecular complex is disclosed. The system includes an electrode electrically coupled to a molecular complex that outputs an electrical signal affected by an electrical property of the molecular complex, wherein the effect of the electrical property of the molecular complex on the electrical signal is characterized by an expected bandwidth. The system further includes an integrating amplifier circuit configured to receive the electrical signal from the electrode. The integrating amplifier circuit is further configured to selectively amplify and integrate a portion of the electrical signal over time within a predetermined bandwidth, wherein the predetermined bandwidth is selected at least in part based on the expected bandwidth.
    Type: Grant
    Filed: November 7, 2018
    Date of Patent: May 26, 2020
    Assignee: Roche Sequencing Solutions, Inc.
    Inventor: Roger J. A. Chen
  • Patent number: 10662473
    Abstract: The present invention is directed to methods and compositions for acquiring nucleotide sequence information of target sequences. In particular, the present invention provides methods and compositions for improving the efficiency of sequencing reactions by using fewer labels to distinguish between nucleotides and by detecting nucleotides at multiple detection positions in a target sequence.
    Type: Grant
    Filed: August 3, 2018
    Date of Patent: May 26, 2020
    Assignee: Complete Genomics, Inc.
    Inventor: Radoje Drmanac
  • Patent number: 10654841
    Abstract: This invention claims processes that comprise the appending of nucleotides having a 3?-ONH2 moiety to the 3?-ends of oligonucleotide primers using 3?-deoxynucleoside triphosphates of 2?-deoxynucleoside derivatives that have, instead of a 3?-OH moiety, a 3?-ONH2 moiety, where the nucleotides contain non-standard nucleobases.
    Type: Grant
    Filed: October 17, 2017
    Date of Patent: May 19, 2020
    Inventors: Steven A Benner, Nicole A Leal
  • Patent number: 10655162
    Abstract: The present disclosure, in some aspects, provides compositions, systems and methods for proximity-based detection of target biomolecules of interest.
    Type: Grant
    Filed: March 3, 2017
    Date of Patent: May 19, 2020
    Assignee: The Broad Institute, Inc.
    Inventors: Alon Goren, Robert Nicol, Harris Nusbaum
  • Patent number: 10655180
    Abstract: The invention provides methods for simultaneously amplifying multiple nucleic acid regions of interest in one reaction volume as well as methods for selecting a library of primers for use in such amplification methods. The invention also provides library of primers with desirable characteristics, such as minimal formation of amplified primer dimers or other non-target amplicons.
    Type: Grant
    Filed: March 14, 2019
    Date of Patent: May 19, 2020
    Assignee: Natera, Inc.
    Inventors: Joshua Babiarz, Tudor Pompiliu Constantin, Lane A. Eubank, George Gemelos, Matthew Micah Hill, Huseyin Eser Kirkizlar, Matthew Rabinowitz, Onur Sakarya, Styrmir Sigurjonsson, Bernhard Zimmermann
  • Patent number: 10658071
    Abstract: Ancestry deconvolution includes obtaining unphased genotype data of an individual; phasing, using one or more processors, the unphased genotype data to generate phased haplotype data; using a learning machine to classify portions of the phased haplotype data as corresponding to specific ancestries respectively and generate initial classification results; and correcting errors in the initial classification results to generate modified classification results.
    Type: Grant
    Filed: November 11, 2015
    Date of Patent: May 19, 2020
    Assignee: 23andMe, Inc.
    Inventors: Chuong Do, Eric Yves Jean-Marc Durand, John Michael Macpherson
  • Patent number: 10656157
    Abstract: The invention generally relates to methods for rare event detection using mass tags. In certain embodiments, the invention provides methods for detecting a target analyte in a sample that involve conducting an assay that specifically associates a mass tag with a target analyte in a sample, generating ions of the mass tag, and analyzing the generated ions of the mass tag, thereby detecting the target analyte from the sample.
    Type: Grant
    Filed: September 23, 2015
    Date of Patent: May 19, 2020
    Assignee: Purdue Research Foundation
    Inventors: Robert Graham Cooks, Zheng Ouyang
  • Patent number: 10648025
    Abstract: Provided herein is technology relating to the amplification-based detection of bisulfite-treated DNAs and particularly, but not exclusively, to methods and compositions for multiplex amplification of low-level sample DNA prior to further characterization of the sample DNA. The technology further provides methods for isolating DNA from blood or blood product samples, e.g., plasma samples.
    Type: Grant
    Filed: December 13, 2017
    Date of Patent: May 12, 2020
    Assignee: EXACT SCIENCES DEVELOPMENT COMPANY, LLC
    Inventors: Hatim T. Allawi, William G. Weisburg, Graham P. Lidgard, Michael W. Kaiser, Abram M. Vaccaro, Gracie Shea
  • Patent number: 10648021
    Abstract: Disclosed are methods and compositions for detection and amplification of nucleic acids, wherein two DNA strands hybridized to an RNA strand are ligated. In one aspect, the disclosed methods include removal of an energy source, such as ATP, upon charging a ligase to form an enzyme-AMP intermediate, and then adding substrate, which results in one complete round of RNA-templated DNA ligation. In another aspect, the ligation reaction is accomplished by use of a mixture of at least two different ligase enzymes. The disclosed methods and compositions for RNA-templated DNA ligation may be particularly useful for detection of RNA sequence variants, for example RNA splice variants, and for quantitative expression analysis.
    Type: Grant
    Filed: October 30, 2017
    Date of Patent: May 12, 2020
    Assignee: AFFYMETRIX, INC.
    Inventors: Eugeni A. Namsaraev, Xin Miao, John E. Blume
  • Patent number: 10648022
    Abstract: A composition includes a nanopore including first and second sides and an aperture, nucleotides each including an elongated tag, and a first polynucleotide that is complementary to a second polynucleotide. A polymerase can be disposed adjacent to the first side of the nanopore and configured to add nucleotides to the first polynucleotide based on a sequence of the second polynucleotide. A permanent tether can include a head region anchored to the polymerase, a tail region, and an elongated body disposed therebetween that occurs in the aperture of the nanopore. A first moiety can be disposed on the elongated body that binds to the elongated tag of a first nucleotide upon which the polymerase is acting. A reporter region can be disposed on the elongated body that indicates when the first nucleotide is complementary or is not complementary to a next nucleotide in the sequence of the second polynucleotide.
    Type: Grant
    Filed: June 2, 2016
    Date of Patent: May 12, 2020
    Assignee: Illumina, Inc.
    Inventors: Kevin L. Gunderson, Jeffrey G. Mandell
  • Patent number: 10640764
    Abstract: There is disclosed a process for in vitro synthesis and assembly of long, gene-length polynucleotides based upon assembly of multiple shorter oligonucleotides synthesized in situ on a microarray platform. Specifically, there is disclosed a process for in situ synthesis of oligonucleotide fragments on a solid phase microarray platform and subsequent, “on device” assembly of larger polynucleotides composed of a plurality of shorter oligonucleotide fragments.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: May 5, 2020
    Assignee: Gen9, Inc.
    Inventor: Andrew V. Oleinikov
  • Patent number: 10641688
    Abstract: A single dissolving compound forms plural azeotropes, which can be azeotropically vaporized off at various stages of the treatment process, thus maintaining predictable concentrations of the chemicals present. The treatment process can be performed in the absence of formalin or related compounds which can interfere with the preservation of genetic material. A process for preserving a specimen includes using a dissolving compound that can form a plural number of azeotropes, at least one azeotrope being formed between one or more components of the dissolving compound and specimen-supplied water, and at least one azeotrope being formed between different components of the dissolving compound; successively and azeotropically vaporizing off formed azeotropes; and impregnating the specimen with a support medium.
    Type: Grant
    Filed: February 23, 2017
    Date of Patent: May 5, 2020
    Inventor: Steven Wheeler
  • Patent number: 10640815
    Abstract: The present disclosure relates to a set of at least 100 single-stranded oligonucleotide probes directed against (or complementary to) portions of a genomic target sequence of interest. The present disclosure also relates to a method of detecting a genomic target sequence of interest using the set of oligonucleotide probes and a method of generating the set of oligonucleotide probes. Further the present disclosure relates to a kit comprising the set of oligonucleotide probes and at least one further component.
    Type: Grant
    Filed: April 22, 2016
    Date of Patent: May 5, 2020
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Frank Bergmann, Walter Eberle, Thomas Fischer, Herbert von der Eltz
  • Patent number: 10640833
    Abstract: The invention generally relates to a method for detecting a target nucleic acid in a sample. This invention is useful for detecting bacterial or viral agents in a sample, and is able to detect nucleic acids from a broad variety of, e.g., bacteria, rather than only one or a few different bacteria at a time.
    Type: Grant
    Filed: June 26, 2015
    Date of Patent: May 5, 2020
    Assignee: University of Florida Research Foundation, Inc.
    Inventors: Kenneth H. Rand, Herbert J. Houck
  • Patent number: 10641764
    Abstract: Droplet-interface bilayer and lipid bilayer membrane compositions stabilized with an amphiphilic polymer are disclosed. Methods of making and using the compositions are also disclosed.
    Type: Grant
    Filed: July 1, 2016
    Date of Patent: May 5, 2020
    Assignee: THE UNIVERSITY OF MASSACHUSETTS
    Inventors: Matthew A. Holden, Max J. Lein, Arash Manafirad, Dan Ezra Aurian-Blajeni
  • Patent number: 10633665
    Abstract: The present disclosure generally relates to novel polynucleotide molecules for use in regulating gene expression in recombinant cells, such as labyrinthulomycetes cells. The disclosure further relates to nucleic acid constructs, such as vectors and expression cassettes, containing a regulatory element operably linked to a heterologous nucleotide sequence. The disclosure further relates to methods for stably transforming a host cell, such as a labyrinthulomycetes cell with transgenes. Stably transformed recombinant cells, progeny, biomaterials derived therefrom, and methods for preparing and using the same are also provided.
    Type: Grant
    Filed: March 8, 2018
    Date of Patent: April 28, 2020
    Assignee: Conagen Inc.
    Inventors: Nicky C. Caiazza, Maung Nyan Win, Jun Urano
  • Patent number: 10626473
    Abstract: Provided herein is a highly sensitive and robust method for Zika detection in semen, as well as related compositions. The method can include: (a) extracting nucleic acids from a human semen sample; (b) detecting Zika virus nonstructural protein 5 (NS5) mRNA using real-time reverse-transcription polymerase chain reaction (rRT-PCR); and (c) simultaneously, in the rRT-PCR, detecting human beta-actin mRNA as positive control.
    Type: Grant
    Filed: October 3, 2017
    Date of Patent: April 21, 2020
    Assignee: Genetics & IVG Institute, Inc.
    Inventors: Brian D. Mariani, Harvey J. Stern
  • Patent number: 10626390
    Abstract: Provided herein are compositions, systems, and methods using multiple ligases, wherein at least one of the ligases is an adenylation-deficient ATP-dependent ligase or an un-adenylated ATP-dependent ligase (e.g., present in an ATP free mixture). In certain embodiments, multiple ligases are used to ligate a pre-adenylated double stranded sequence to a non-adenylated double stranded sequence (e.g., the adenylation-deficient ATP-dependent ligase or un-adenylated ATP-dependent ligase ligates the first strand, and a second ligase ligates the second strand). In other embodiments, provided herein are mutant T4 ligases (e.g., K159S mutant or K159C mutant).
    Type: Grant
    Filed: February 7, 2017
    Date of Patent: April 21, 2020
    Assignee: RGENE, INC.
    Inventors: Yu Zheng, Manqing Hong
  • Patent number: 10626401
    Abstract: The invention relates to non-CpG single-stranded oligonucleotides (ssONs) for use in the treatment or prophylaxis of disorders of the skin and/or subcutaneous tissue, including pruritus, in a suitable formulation or in combination with other immunomodulatory treatments. The said ssONs have a length of at least 25 nucleotides and are stabilized by phosphorothioate internucleotide linkages and/or 2?-O-Methyl modifications.
    Type: Grant
    Filed: June 14, 2016
    Date of Patent: April 21, 2020
    Assignee: TIRMED PHARMA AB
    Inventors: Anna-Lena Spetz, Peter Jarver, Annette Skold
  • Patent number: 10626436
    Abstract: A method of determining variation between a query cell culture media and a reference cell culture media is provided. The method comprises the steps of incubating a reference cell with an aliquot of the query culture media and at least three chemical cell stressors in wells of a microtitre plate and determining an environmental response of the reference cell in the presence of the query cell culture media and each of the plurality of chemical cell stressors. A query cell culture media specific environmental response fingerprint is generated comprising the plurality of chemical cell stressor specific environmental responses. The query cell culture media-specific environmental response fingerprint is compared with a reference media-specific environmental response fingerprints corresponding to a reference cell culture media and generated using the reference cell.
    Type: Grant
    Filed: April 1, 2016
    Date of Patent: April 21, 2020
    Assignee: Valitacell Limited
    Inventors: Jerry Clifford, David James, Ben Thompson